Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05670457

Diosmin as Adjuvant Therapy in Treatment of Non-bleeding Peptic Ulcer

Conditions: Non-bleeding Peptic Ulcer

Sex: All

Ages: 25 Years – 65 Years

Phase: PHASE3

Enrollment: 44

Sponsor: Tanta University

Location: Egypt

Summary

The aim of the study is to evaluate the safety and efficacy of diosmin as adjuvant therapy in treatment of non-bleeding peptic ulcer patients.

Eligibility Criteria

Inclusion Criteria:-. Age 25-65 years old.Patients of both gender (male and female).Non-bleeding Peptic ulcer Patients (duodenal &gastric) diagnosed by endoscopy.Exclusion Criteria:The presence of other factors that can lead to gastric bleeding other than peptic ulcer.Patients with cancerous diseaseBreast-feeding.Surgically altered stomach ( bariatric surgery),Patient with liver disease.Bleeding & perforated peptic ulcer.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05670457). StuddyBuddy aggregates publicly available trial information.